New substances: AquAdvantage® salmon
Notifier: AquaBounty Technologies Inc.
New Substances Notification (NSN) number: 19702
Substance designation: AquAdvantage® salmon
Assessment period: July 28, 2018 to March 24, 2019
Activity: AquaBounty Technologies is constructing new production facilities to meet the growing global demand for AquAdvantage® salmon. One facility will be used to produce eggs for farming of AquAdvantage® salmon in the company’s facilities in Canada, the United States and Panama. The other facilities will be used to produce AquAdvantage® salmon for commercial sale in Canada and/or export to other countries.
Genetic modifications: AquAdvantage® salmon was developed by engineering a St. John River salmon with two genes from the Pacific salmon and from the Ocean Pout for expression of a growth hormone gene in AquAdvantage® salmon. AquAdvantage® salmon reaches a size of 100 g faster than non-engineered counterparts.
Public comments period: Sept 14, 2018 to Oct 12, 2018
Public comments received: Summary of public comments received
Risk assessment and science advisory report
Canadian Science Advisory Secretariat Science Advisory Report 2019/014 on the environmental and indirect human health risk assessment for AquAdvantage® salmon at a contained facility near Rollo Bay, PEI
Waiver of information requirement
Significant New Activity notice
Report a problem or mistake on this page
- Date modified: